Imagenebio Inc (IMA)

$15.20 -1.17 (-7.15%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	3.50M
Net Income (ttm)	-36.57M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	-1,044.80%
Debt to Equity Ratio	N/A

Volume	25,400
Avg Vol	19,682
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	22%
Beta	N/A
Analysts	Strong Sell
Price Target	$132.05

Company Profile

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 617-901-7098

Website: www.inmagenebio.com

Address:

12526 High Bluff Drive, Suite 345, San Diego, United States

CumulativeChaser Aug. 1 at 5:57 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $CHRW $NSPR $APLS $JZXN $IMA

0 · Reply

WallStArb Jul. 31 at 7:41 PM

$IMA $IKNA my largest position --> PIPE owners have incentive to push this to $350M mkt cap which is around $30 - $35 --> as I have been saying this is my low risk - just wait and let them push it up like $TECX

0 · Reply